Ramat Gan, Israel

Roni Haklai

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Ramot University Authority for Applied Research and Industrial Development Limited, Tel Aviv University. Active years: 2002-2012.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roni Haklai: Innovator in Cancer Treatment and Drug Screening

Introduction

Roni Haklai is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of lung cancer and drug screening methodologies. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry and improve patient outcomes.

Latest Patents

Haklai's latest patents include innovative methods for treating lung cancer. These methods involve administering effective amounts of Farnesyl Thiosalicylic Acid (FTS) or its analogs, optionally in combination with chemotherapeutic agents. This approach aims to enhance the efficacy of cancer treatments. Another significant patent focuses on a drug screening assay designed to identify compounds that affect long-chain fatty acid-dependent intracellular membrane anchorage sites of lipoproteins. This assay is adaptable and can be utilized in various pharmacological applications, addressing a wide range of medical needs.

Career Highlights

Throughout his career, Roni Haklai has worked with esteemed institutions such as Ramot University Authority for Applied Research and Industrial Development Limited and Tel Aviv University. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research.

Collaborations

Haklai has collaborated with notable colleagues, including Yoel Kloog and Ariella Paz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking research.

Conclusion

Roni Haklai's contributions to cancer treatment and drug screening exemplify the impact of innovation in the medical field. His patents and collaborations highlight the importance of research in developing effective therapies. His work continues to inspire advancements in healthcare and pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…